These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

702 related articles for article (PubMed ID: 26222205)

  • 21. Pediatric-onset multiple sclerosis in Brazilian patients: Clinical features, treatment response and comparison to pediatric neuromyelitis optica spectrum disorders.
    Fragomeni MO; Bichuetti DB; Oliveira EML
    Mult Scler Relat Disord; 2018 Oct; 25():138-142. PubMed ID: 30075406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antineutrophil cytoplasmic antibodies in patients with idiopathic inflammatory-demyelinating diseases.
    Long Y; Zheng Y; Chen M; Zhang B; Gao C; Gao Q; Yin JR; Pu S; Xie C
    Neuroimmunomodulation; 2014; 21(6):297-303. PubMed ID: 24642629
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemiological findings of neuromyelitis optica spectrum disorders in a Venezuelan study.
    Ibis SC; Omaira M; Arnoldo S; Elizabeth A; Sandra M; Carlota CM; Elizabeth C; Laura V; Rosalba L; Oscar V; Luisa DM; Nahir A; Hernandez F
    Mult Scler Relat Disord; 2021 Jan; 47():102652. PubMed ID: 33279797
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcome prediction models in AQP4-IgG positive neuromyelitis optica spectrum disorders.
    Palace J; Lin DY; Zeng D; Majed M; Elsone L; Hamid S; Messina S; Misu T; Sagen J; Whittam D; Takai Y; Leite MI; Weinshenker B; Cabre P; Jacob A; Nakashima I; Fujihara K; Pittock SJ
    Brain; 2019 May; 142(5):1310-1323. PubMed ID: 30938427
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Seroprevalence and diagnostic value of aquaporin-4 antibody in patients with inflammatory central nervous system demyelinating diseases].
    Wu L; Yang Y; Huang DH; Wu WP
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Feb; 31(2):350-2. PubMed ID: 21354891
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterisation of the spectrum of demyelinating disease in Western Australia.
    Wu JS; Zhang MN; Carroll WM; Kermode AG
    J Neurol Neurosurg Psychiatry; 2008 Sep; 79(9):1022-6. PubMed ID: 18356258
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onset.
    Collongues N; Marignier R; Jacob A; Leite MI; Siva A; Paul F; Zephir H; Akman-Demir G; Elsone L; Jarius S; Papeix C; Mutch K; Saip S; Wildemann B; Kitley J; Karabudak R; Aktas O; Kuscu D; Altintas A; Palace J; Confavreux C; De Seze J
    Mult Scler; 2014 Jul; 20(8):1086-94. PubMed ID: 24323817
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study.
    Kitley J; Waters P; Woodhall M; Leite MI; Murchison A; George J; Küker W; Chandratre S; Vincent A; Palace J
    JAMA Neurol; 2014 Mar; 71(3):276-83. PubMed ID: 24425068
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term follow-up of neuromyelitis optica with a pediatric onset.
    Collongues N; Marignier R; Zéphir H; Papeix C; Fontaine B; Blanc F; Rodriguez D; Fleury M; Vukusic S; Pelletier J; Audoin B; Thouvenot E; Camu W; Barroso B; Ruet A; Brochet B; Vermersch P; Confavreux C; de Seze J
    Neurology; 2010 Sep; 75(12):1084-8. PubMed ID: 20855851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuromyelitis optica in Portugal (NEMIPORT) - A multicentre study.
    Domingos J; Isidoro L; Figueiredo R; Brum M; Capela C; Barros P; Santos E; Macário Mdo C; Pinto Marques J; Pedrosa R; Vale J; Sá MJ
    Clin Neurol Neurosurg; 2015 Jul; 134():79-84. PubMed ID: 25965287
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Central nervous system inflammatory demyelinating disorders among Hong Kong Chinese.
    Chan KH; Lee R; Lee JC; Tse AC; Pang SY; Lau GK; Teo KC; Ho PW
    J Neuroimmunol; 2013 Sep; 262(1-2):100-5. PubMed ID: 23838529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-risk syndrome for neuromyelitis optica: a descriptive and comparative study.
    Collongues N; Marignier R; Zéphir H; Blanc F; Vukusic S; Outteryck O; Fleury M; Ruet A; Borgel F; Thouvenot E; Moreau T; Defer G; Derache N; Pelletier J; Audoin B; Debouverie M; Labauge P; Gout O; Camu W; Brassat D; Brochet B; Vermersch P; Confavreux C; de Seze J
    Mult Scler; 2011 Jun; 17(6):720-4. PubMed ID: 21239412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aquaporin-4 antibody-positive cases beyond current diagnostic criteria for NMO spectrum disorders.
    Sato DK; Nakashima I; Takahashi T; Misu T; Waters P; Kuroda H; Nishiyama S; Suzuki C; Takai Y; Fujihara K; Itoyama Y; Aoki M
    Neurology; 2013 Jun; 80(24):2210-6. PubMed ID: 23677744
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autoimmunity in neuromyelitis optica and opticospinal multiple sclerosis: astrocytopathy as a common denominator in demyelinating disorders.
    Kira J
    J Neurol Sci; 2011 Dec; 311(1-2):69-77. PubMed ID: 21962794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese.
    Matsuoka T; Matsushita T; Kawano Y; Osoegawa M; Ochi H; Ishizu T; Minohara M; Kikuchi H; Mihara F; Ohyagi Y; Kira J
    Brain; 2007 May; 130(Pt 5):1206-23. PubMed ID: 17439988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Evaluation of diagnostic value for NMO-IgG in patients with neuromyelitis optica].
    Yang Y; Huang DH; Wu L; Wu WP
    Zhonghua Yi Xue Za Zhi; 2010 Mar; 90(9):606-9. PubMed ID: 20450783
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spectral-domain optical coherence tomography of retinal nerve fiber layer thickness in NMO patients.
    Lange AP; Sadjadi R; Zhu F; Alkabie S; Costello F; Traboulsee AL
    J Neuroophthalmol; 2013 Sep; 33(3):213-9. PubMed ID: 23863782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microcystic inner nuclear layer abnormalities and neuromyelitis optica.
    Gelfand JM; Cree BA; Nolan R; Arnow S; Green AJ
    JAMA Neurol; 2013 May; 70(5):629-33. PubMed ID: 23529376
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is Devic's neuromyelitis optica a separate disease? A comparative study with multiple sclerosis.
    de Seze J; Lebrun C; Stojkovic T; Ferriby D; Chatel M; Vermersch P
    Mult Scler; 2003 Oct; 9(5):521-5. PubMed ID: 14582780
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of the spectrum of Korean inflammatory demyelinating diseases according to the diagnostic criteria and AQP4-Ab status.
    Kim SM; Waters P; Woodhall M; Yang JW; Yang H; Kim JE; Sung JJ; Park KS; Lee KW
    BMC Neurol; 2014 Apr; 14():93. PubMed ID: 24779645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.